Also, M6a is downregulated in the hippocampal formation whereas it is enriched in extracellular vesicles from cerebrospinal fluid (CSF) samples of AD patients suggesting an active secretion of M6a during AD progression (Xu et al., 2006; Chiasserini et al., 2020). The gene discussed is GPM6A; the disease is Alzheimer disease.